This study is designed to answer whether minimal invasive vessel clotting (angioembolization) or open surgery (retroperitoneal packing) is more effective for pelvic fractures with massive bleeding. Patients admitted at daytime (7am-5pm) are treated with angioembolization while patients admitted at nighttime (5pm to 7am) are treated with open surgery.
In patients with pelvic fracture uncontrollable bleeding is the major cause of death within the first 24h after injury. Early hemorrhage control is therefore vital for successful treatment. Nowadays, recommended techniques for hemorrhage control in pelvic fractures are retroperitoneal pelvic packing and angioembolization, dependent upon the available technical staff and resources and the condition of the patient. Retroperitoneal pelvic packing, on the one hand, is a relatively simple method in controlling pelvic hemorrhage even with limited resources. Since 89% of pelvic fracture hemorrhage originates from venous bleeding, fracture stabilization and compressive hemostasis by packing is a reasonable approach. Angioembolization, on the other hand, has great high effectiveness with regard to bleeding control, but requires an angiography suite and technical staff. Since hemostasis of retroperitoneal venous bleeding often can be achieved by external pelvic fixation, angioembolization is required for the 11% arterial bleedings which are hard to control by packing. Even though many authors see both methods as complements, time is crucial in the multitrauma setting and the severely injured patient does not tolerate multiple interventions well. Until now good predictors for treatment choice are unavailable, and management of hemodynamically unstable pelvic fractures remains a matter of debate. This study was designed to answer following questions: * Is retroperitoneal pelvic packing or angiography superior with regard to in-hospital mortality, complications, required secondary procedures, or post-intervention blood loss? * Which of these methods is the more rapid intervention in the acute setting?
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
56
Shandong Provincial Hospital
Jinan, Shandong, China
Number of participants deceased occurring in-hospital during or after treatment with packing or embolization
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Number of postoperative packed red blood cell units administered for each participant
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Number of participants which required a secondary procedure (PACKING or ANGIO) after the primary intervention (PACKING or ANGIO)
Packing for ANGIO and angioembolization for PACKING.
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Time from admission (in minutes) to treatment (PACKING or ANGIO) for each participant
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Procedural/surgical time (in minutes) for each participant
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Days on ICU for each participant
Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.